Difference between revisions of "International Mito Patients (IMP)"
From Bioblast
Beno Marija (talk | contribs) |
Beno Marija (talk | contribs) |
||
Line 8: | Line 8: | ||
}} | }} | ||
==Chairman== | |||
==Contact details== | |||
===Chairman=== | |||
::::Elja van der Veer (The Netherlands) | ::::Elja van der Veer (The Netherlands) | ||
::::Main responsibility: general management, project harmful drugs for mito’s | ::::Main responsibility: general management, project harmful drugs for mito’s | ||
::::[mailto:[email protected] [email protected]] | ::::[mailto:[email protected] [email protected]] | ||
==Business address== | ===Business address=== | ||
::::International Mito Patients | ::::International Mito Patients | ||
::::Burg. Uilkensstraat 21 | ::::Burg. Uilkensstraat 21 | ||
::::2861 AD Bergambacht - The Netherlands | ::::2861 AD Bergambacht - The Netherlands | ||
::::Email: [mailto:[email protected] [email protected]] | ::::Email: [mailto:[email protected] [email protected]] |
Revision as of 18:14, 22 March 2017
- high-resolution terminology - matching measurements at high-resolution
International Mito Patients (IMP)
Description
The International Mito Patients is a network of national patient organizations involved in mitochondrial disease. Mitochondrial disease is a rare disease with a limited number of patients per country. The national patient organizations which are a member of IMP each are active and powerful in their own countries. By joining forces IMP can represent a large group of patients and as such be their voice on an international level.
Abbreviation: IMP
Reference: MitoPatients
MitoPedia topics:
MitoGlobal Organizations
Contact details
Chairman
- Elja van der Veer (The Netherlands)
- Main responsibility: general management, project harmful drugs for mito’s
- [email protected]
Business address
- International Mito Patients
- Burg. Uilkensstraat 21
- 2861 AD Bergambacht - The Netherlands
- Email: [email protected]